ReP USP - Resultado da busca

Artigo de periodico
Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy (2019)
Schmidt, Andre ; Romano, Minna Moreira Dias ; Marin Neto, José Antonio; Rao-Melacini, Purnima; Rassi, Anis; Mattos, Antônio; Avezum Junior, Álvaro ; Villena, Erick; Sosa-Estani, Sergio; Bonilla, Rina; Yusuf, Salim; Morillo, Carlos A.; Maciel, Benedito Carlos
Source: Journal of the American Society of Echocardiography. Unidade: FMRP
Subjects: MIOCARDIOPATIA CONGESTIVA, ECOCARDIOGRAFIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHMIDT, Andre et al. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy. Journal of the American Society of Echocardiography, v. 32, n. 2, p. 286-295, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.echo.2018.09.006. Acesso em: 16 nov. 2024.
APA
Schmidt, A., Romano, M. M. D., Marin Neto, J. A., Rao-Melacini, P., Rassi, A., Mattos, A., et al. (2019). Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy. Journal of the American Society of Echocardiography, 32( 2), 286-295. doi:10.1016/j.echo.2018.09.006
NLM
Schmidt A, Romano MMD, Marin Neto JA, Rao-Melacini P, Rassi A, Mattos A, Avezum Junior Á, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy [Internet]. Journal of the American Society of Echocardiography. 2019 ; 32( 2): 286-295.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.echo.2018.09.006
Vancouver
Schmidt A, Romano MMD, Marin Neto JA, Rao-Melacini P, Rassi A, Mattos A, Avezum Junior Á, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC. Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a BENEFIT trial echocardiographic substudy [Internet]. Journal of the American Society of Echocardiography. 2019 ; 32( 2): 286-295.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.echo.2018.09.006
Artigo de periodico
Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) (2018)
Acquatella, Harry; Asch, Federico M.; Barbosa, Marcia M.; Barros, Marcio; Bern, Caryn; Cavalcante, Joao L.; Echeverria Correa, Luis Eduardo; Lima, Joao; Marcus, Rachel; Marin Neto, José Antonio; Migliore, Ricardo; Milei, Jose; Morillo, Carlos A.; Nunes, Maria Carmo Pereira; Vieira, Marcelo Luiz Campos; Viotti, Rodolfo
Source: Journal of the American Society of Echocardiography. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, MIOCARDIOPATIA CONGESTIVA, ANEURISMA, VENTRÍCULO CARDÍACO, ECOCARDIOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ACQUATELLA, Harry et al. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, v. 31, n. 1, p. 3-25, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.echo.2017.10.019. Acesso em: 16 nov. 2024.
APA
Acquatella, H., Asch, F. M., Barbosa, M. M., Barros, M., Bern, C., Cavalcante, J. L., et al. (2018). Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC). Journal of the American Society of Echocardiography, 31( 1), 3-25. doi:10.1016/j.echo.2017.10.019
NLM
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Vancouver
Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, Echeverria Correa LE, Lima J, Marcus R, Marin Neto JA, Migliore R, Milei J, Morillo CA, Nunes MCP, Vieira MLC, Viotti R. Recommendations for multimodality cardiac imaging in patients with chagas disease: a report from the american society of echocardiography in collaboration with the interamerican association of echocardiography (ECOSIAC) and the cardiovascular imaging department of the brazilian society of cardiology (DIC-SBC) [Internet]. Journal of the American Society of Echocardiography. 2018 ; 31( 1): 3-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.echo.2017.10.019
Artigo de periodico
Cholesterol lowering in intermediate-risk persons without cardiovascular disease (2016)
Yusuf, S.; Marin Neto, José Antonio; Gao, P.; Diaz, R.; Lonn, E.
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), ADESÃO À MEDICAÇÃO, HIPERCOLESTEROLEMIA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUSUF, S. et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2021-2031, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600176. Acesso em: 16 nov. 2024.
APA
Yusuf, S., Marin Neto, J. A., Gao, P., Diaz, R., & Lonn, E. (2016). Cholesterol lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2021-2031. doi:10.1056/NEJMoa1600176
NLM
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1600176
Vancouver
Yusuf S, Marin Neto JA, Gao P, Diaz R, Lonn E. Cholesterol lowering in intermediate-risk persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2021-2031.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1600176
Artigo de periodico
Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics (2016)
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J.; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J. G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim; Marin Neto, José Antonio
Source: Canadian Journal of Cardiology. Unidade: FMRP
Subjects: RECEPTORES DE ANGIOTENSINA, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva et al. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, v. 32, n. 3, p. 311-318, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2015.07.001. Acesso em: 16 nov. 2024.
APA
Lonn, E., Bosch, J., Pogue, J., Avezum, A., Chazova, I., Dans, A., et al. (2016). Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, 32( 3), 311-318. doi:10.1016/j.cjca.2015.07.001
NLM
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Vancouver
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Artigo de periodico
Blood-pressure and cholesterol lowering in persons without cardiovascular disease (2016)
Yusuf, Salim; Marin Neto, José Antonio; Diaz, Rafael; Dans, Antonio; Dagenais, Gilles
Source: New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, FÁRMACOS (SISTEMA CARDIOVASCULAR), ADESÃO À MEDICAÇÃO, HIPERTENSÃO, COLESTEROL, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUSUF, Salim et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. New England Journal of Medicine, v. 374, n. 21, p. 2032-2043, 2016Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1600177. Acesso em: 16 nov. 2024.
APA
Yusuf, S., Marin Neto, J. A., Diaz, R., Dans, A., & Dagenais, G. (2016). Blood-pressure and cholesterol lowering in persons without cardiovascular disease. New England Journal of Medicine, 374( 21), 2032-2043. doi:10.1056/NEJMoa1600177
NLM
Yusuf S, Marin Neto JA, Diaz R, Dans A, Dagenais G. Blood-pressure and cholesterol lowering in persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2032-2043.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1600177
Vancouver
Yusuf S, Marin Neto JA, Diaz R, Dans A, Dagenais G. Blood-pressure and cholesterol lowering in persons without cardiovascular disease [Internet]. New England Journal of Medicine. 2016 ; 374( 21): 2032-2043.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1600177
Artigo de periodico
Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy (2015)
Morillo, Carlos A.; Marin Neto, José Antonio; Avezum, Álvaro; Sosa-Estani, Sergio; Rassi Júnior, Anis; Rosas, Fernando; Villena, Erick; Quiroz, Roberto; Bonilla, Rina; Britto, Constança; Guhl, Felipe; Velázquez, Elsa; Bonilla, Laura; Meeks, Brandi; Rao-Melacini, Purnima; Pogue, Janice; Mattos, Antônio; Lazdins, Janis; Rassi, Anis; Connolly, Stuart J.; Yusuf, Salim; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, TERAPÊUTICA MÉDICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORILLO, Carlos A. et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, v. 373, n. 14, p. 1295-1306, 2015Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1507574. Acesso em: 16 nov. 2024.
APA
Morillo, C. A., Marin Neto, J. A., Avezum, Á., Sosa-Estani, S., Rassi Júnior, A., Rosas, F., et al. (2015). Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, 373( 14), 1295-1306. doi:10.1056/NEJMoa1507574
NLM
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1507574
Vancouver
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1056/NEJMoa1507574

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration